Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 312.50 | 180.13 | 174.00 | 257.25 | 0.6764 | -0.0651 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 4 | 312.50 | 180.13 | 192.00 | 257.25 | 0.7464 | 0.1322 |
| SK-BR-3 | Taxol | 0.31623 | uM | 4 | 312.50 | 180.13 | 159.00 | 257.25 | 0.6181 | -0.2154 |
| SK-BR-3 | Taxol | 1 | uM | 4 | 312.50 | 180.13 | 152.00 | 257.25 | 0.5909 | -0.2812 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 4 | 312.50 | 180.13 | 143.00 | 257.25 | 0.5559 | -0.3617 |
| SK-BR-3 | Palbociclib | 10 | uM | 4 | 312.50 | 180.13 | 169.00 | 257.25 | 0.6570 | -0.1166 |
| SK-BR-3 | Taxol | 0.01 | uM | 4 | 312.50 | 180.13 | 144.00 | 257.25 | 0.5598 | -0.3530 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 4 | 312.50 | 180.13 | 188.00 | 257.25 | 0.7308 | 0.0868 |
| SK-BR-3 | Methotrexate | 1 | uM | 4 | 312.50 | 180.13 | 269.00 | 257.25 | 1.0457 | 1.1815 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 265.00 | 257.25 | 1.0301 | 1.1189 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 192.00 | 257.25 | 0.7464 | 0.1322 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 211.00 | 257.25 | 0.8202 | 0.3603 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 141.00 | 257.25 | 0.5481 | -0.3789 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 228.00 | 257.25 | 0.8863 | 0.5815 | |
| SK-BR-3 | Taxol | 0.00033113 | uM | 4 | 312.50 | 180.13 | 278.00 | 257.25 | 1.0807 | 1.3257 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 4 | 312.50 | 180.13 | 280.00 | 257.25 | 1.0884 | 1.3583 |
| SK-BR-3 | Omipalisib | 1 | uM | 4 | 312.50 | 180.13 | 153.00 | 257.25 | 0.5948 | -0.2720 |
| SK-BR-3 | Methotrexate | 10 | uM | 4 | 312.50 | 180.13 | 289.00 | 257.25 | 1.1234 | 1.5080 |
| SK-BR-3 | Palbociclib | 1 | uM | 4 | 312.50 | 180.13 | 193.00 | 257.25 | 0.7502 | 0.1437 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 312.50 | 180.13 | 322.00 | 257.25 | 1.2517 | 2.0950 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 312.50 | 180.13 | 162.00 | 257.25 | 0.6297 | -0.1864 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 4 | 312.50 | 180.13 | 466.00 | 257.25 | 1.8115 | 5.3514 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 312.50 | 180.13 | 186.00 | 257.25 | 0.7230 | 0.0644 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 263.00 | 257.25 | 1.0224 | 1.0879 | |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 312.50 | 180.13 | 263.00 | 257.25 | 1.0224 | 1.0879 |